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b-Keto amides are really very convenient and versatile building
blocks in organic synthesis since they possess several reactive
active sites in the same molecule [10] as reﬂected by the pleth-
ora of publications and reviews [2–4]. By selectively regulating
the different active positions, we can rationally utilize one,
two, or multiple sites of the reactive active sites to construct
many heterocyclic compounds [5,6] and other useful organic
compounds [7,8]. Recently, we reported a self-condensation
cyclization reaction of b-ketobutylanilides [1,9,10] to synthe-
size polysubstituted 4-pyridones and 2-pyridones mediated
by a combination of phosphorus pentoxide (P2O5) with zinc
bromide (ZnBr2) [11]. During the course of conditional optimi-
zation studies, we found a very interesting phenomenon thatthe reaction provided an unexpected product as the major
product, which was subsequently characterized as N-phenyl-
formamide by 1H NMR, 13C NMR and IR analysis, only
when using P2O5 as the catalyst at 100 C in N,N-dimethyl
formamide (DMF) (Scheme 1). Based on this result, we devel-
oped a novel approach to the synthesis of N-phenylamides
using dimethylformamide (DMF) and dimethylacetamide
(DMA) as the acyl donors, on which we report herein. To
the best of our knowledge, amides and their derivatives are
very important organic materials in organic synthesis [12,13]
and have been widely used in the synthesis of many biologi-
cally and pharmaceutically active compounds [14,15]. So far,
despite there being many reports for the synthesis of amides
[16–18], there are only very limited reports [19] for acylation
reactions using DMF and DMA as the acyl donors.
2. Experimental
2.1. General
All the reactions were carried out at 120 C for 12 h in a
Schlenk tube equipped with magnetic stir bar. Solvents and
reagents purchased from Aldrich Chemicals or J&K Scientiﬁc
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Scheme 1 Synthesis of N-phenylformamide.
328 C. Chen et al.Ltd., were used as received. Petroleum ether (PE) refers to the
fraction boiling in the 60–90 C range. Thin-layer chromatog-
raphy was performed using Qingdao-Haiyang 600 mesh silica
gel plates (GF254), and samples were made visual with
short-wavelength UV light (254 nm). Melting points were mea-
sured on a melting point apparatus equipped with a thermom-
eter and were uncorrected. IR spectra were recorded on a
Bruker Vector 22 spectrometer as KBr pellets. 1H NMR and
13C NMR spectra were recorded on a 400 MHz spectrometer
in solutions of CDCl3 using tetramethylsilane as the internal
standard, d values are given in ppm and coupling constants
(J) in Hz. GC–MS was obtained using an electron ionization
(EI) Agilent 6890 N/5973 mass spectrometer.
Typical procedure for N-phenylformamide (Table 2, entry 1):
A mixture of 3-oxo-N-phenylbutanamide (1a) (177 mg, 1.0
mmol), HCl (6.3 mg, 0.2 mmol) and DMF (2.0 mL) was added
successively in a Schlenk tube, and the resulting solution
stirred for 12 h at 120 C. The mixture was then subjected to
puriﬁcation by preparative thin-layer chromatography (PE–
EtOAc, 10:3) to afford product 2a (106.6 mg, 88%).
Characterization data for all prepared compounds:
N-phenylformamide (Table 2, entry 1) [19]: 1H NMR
(CDCl3, 400 MHz) d= 8.66 (d, J= 11.2 Hz, 0.5H), 8.47 (s, 0.5
H), 8.34 (s, 0.5H), 7.61 (s, 0.5H), 7.52 (d, J= 7.6 Hz, 1H), 7.31
(dd, J= 7.6 Hz, J= 7.6 Hz, 2H), 7.11 (m, 2H); 13C NMR
(CDCl3, 100 MHz) d= 162.8, 159.2, 136.9, 136.7, 129.7, 129.1,
125.3, 124.8, 120.5, 118.8.
N-o-tolylformamide (Table 2, entry 2) [20]: 1H NMR
(CDCl3, 400 MHz) d= 8.53 (d, J= 11.2 Hz, 0.6H), 8.42 (s, 0.4
H), 7.87 (d, J= 8.0 Hz, 0.4H), 7.77 (s, 0.6H), 7.15 (m, 4.0H),
2.28 (s, 1.8H), 2.26 (s, 1.2H); 13C NMR (CDCl3, 100 MHz)
d= 163.1, 159.0, 134.9, 134.6, 131.2, 130.5, 127.1, 126.8, 126.0,
125.5, 123.0, 120.6, 17.7, 17.6.
N-(2,5-dichlorophenyl)formamide (Table 2, entry 3) Pale
yellow crystals; mp 151.1–152.4 C; IR mmax (KBr): 3241,
2862, 1668, 1611, 1523, 1447, 1410, 1255, 804, 783, 684 cm1;
1H NMR (CDCl3, 400 MHz) d= 8.73 (d, J= 11.2 Hz, 0.2H),
8.51 (s, 1H), 6.90 (d, J= 6.4 Hz, 1.6H), 7.70 (s, 1H), 7.37 (d,
J= 8.8 Hz, 0.2H), 7.31 (d, J= 8.8 Hz, 1H), 7.12 (d,
J= 8.4 Hz, 0.2H), 7.06 (d, J= 8.4 Hz, 3H);13C NMR (CDCl3,
100 MHz) d= 160.8, 158.6, 134.5, 134.4, 134.4, 133.8, 133.6,
131.1, 129.7, 125.7, 125.0, 121.7, 120.4, 118.2; MS (EI) m/z
(%):153.95 (100); 189.85 (19.31); Anal. Calcd for C7H5Cl2NO:
C, 44.24; H, 2.65; N, 7.37; Found: C, 44.41; H, 2.59; N, 7.50.
N-p-tolylformamide (Table 2, entry 4) CAS: 3085-54-9; 1H
NMR (CDCl3, 400 MHz) d= 8.53 (d, J= 11.6 Hz, 0.5H),
8.31 (s, 0.5H), 8.17 (s, 0.5H), 7.44 (d, J= 8.4 Hz, 1.0 H), 7.12
(dd, J= 8.4 Hz, J= 8.4 Hz, 2H), 6.96 (d, J= 8.4 Hz, 1.0 H),
2.31 (s, 1.5H), 2.29 (s, 1.5H); 13C NMR (CDCl3, 100 MHz)
d= 162.7, 159.0, 135.1, 134.5, 134.3, 134.1, 130.2, 129.5,
120.7, 119.2, 20.8, 20.7.
N-(2,4-dimethylphenyl)formamide (Table 2, entry 5) CAS:
60397-77-5; 1H NMR (CDCl3, 400 MHz) d= 8.43 (d,J= 11.2 Hz, 0.6H), 8.37 (s, 0.4H), 8.08 (s, 0.6H), 7.65 (d,
J= 8.4 Hz, 0.4H), 7.28 (s, 0.4H), 6.99 (s, 0.6 H), 6.95 (s,
2.0H), 2.25 (s, 2.0H), 2.23 (s, 1.0H), 2.21 (s, 2.0H), 2.17 (s,
1.0H); 13C NMR (CDCl3, 100 MHz) d= 163.6, 159.3, 135.9,
135.3, 132.4, 131.9, 131.8, 131.2, 130.1, 127.5, 127.2, 123.4,
121.3, 20.8, 20.7, 17.6, 17.6.
N-(2-chlorophenyl)formamide (Table 2, entry 6) [21]: 1H
NMR (CDCl3, 400 MHz) d= 8.67 (d, J= 11.2 Hz, 0.3H),
8.46 (s, 0.7H), 8.36 (d, J= 8.4 Hz, 0.7H), 7.74 (s, 1H), 7.39
(d, J= 8.0 Hz, 0.3H), 7.34 (d, J= 8.0 Hz, 0.7 H), 7.23 (m,
1.3H), 7.10 (m, 0.3H), 7.03 (t, J= 8.0 Hz, 0.7H); 13C NMR
(CDCl3, 100 MHz) d= 161.5, 158.8, 133.7, 130.3, 129.1,
128.0, 127.8, 125.9, 125.1, 122.5, 122.0, 118.7.
N-(4-chlorophenyl)formamide (Table 2, entry 7) CAS: 2617-
79-0; 1H NMR (CDCl3, 400 MHz) d= 8.85 (s, 0.4H), 8.66
(d, J= 11.2 Hz, 0.4H), 8.35 (s, 0.6H), 8.06 (s, 0.6H), 7.49 (d,
J= 8.8 Hz, 1.2H), 7.30 (d, J= 8.8 Hz, 0.8 H), 7.28 (d,
J= 8.8 Hz, 1.2 H), 7.05 (d, J= 8.0 Hz, 0.8H); 13C NMR
(CDCl3, 100 MHz) d= 162.7, 159.3, 135.5, 135.3, 130.7,
129.8, 129.1, 121.5, 121.3, 120.6.
N-(2-methoxyphenyl)formamide (Table 2, entry 8) CAS:
23896-88-0; 1H NMR (CDCl3, 400 MHz) d= 8.70 (d,
J= 11.6 Hz, 0.3H), 8.40 (s, 0.7H), 8.70 (d, J= 11.6 Hz,
0.3H), 7.76 (s, 0.6H), 7.74 (s, 1H), 7.49 (d, J= 8.8 Hz,
1.2H), 8.33 (d, J= 8.0 Hz, 0.7 H), 7.82 (s, 0.7H), 7.69 (s,
0.3H), 7.17 (d, J= 7.6 Hz, 0.3H), 7.10 (t, J= 8.0 Hz, 0.3H),
8.05 (d, J= 8.0 Hz, 0.7H), 6.91 (m, 2.0H), 3.86 (s, 2.1H),
3.84 (s, 0.9H); 13C NMR (CDCl3, 100 MHz) d= 161.4,
158.7, 147.8, 126.7, 125.2, 124.2, 121.1, 121.0, 116.6, 116.5,
111.3, 110.0, 55.7, 55.7.
N-(4-methoxyphenyl)formamide (Table 2, entry 9) [22]: 1H
NMR (CDCl3, 400 MHz) d= 8.47 (d, J= 11.6 Hz, 0.5H),
8.28 (s, 0.5H), 8.17 (s, 0.5H), 7.52 (s, 0.5H), 7.41 (d,
J= 8.8 Hz, 1.0H), 7.01 (d, J= 8.8 Hz, 1.0H), 7.01 (dd,
J= 8.8 Hz, J= 8.8 Hz, 2.0H), 3.77 (s, 1.5H), 3.75 (s, 1.5H);
13C NMR (CDCl3, 100 MHz) d= 163.1, 159.0, 157.6, 156.7,
129.9, 129.5, 121.8, 121.6, 114.9, 114.2, 55.5, 55.4.
N-(4-ethoxyphenyl)formamide (Table 2, entry 10) [22]: 1H
NMR (CDCl3, 400 MHz) d= 8.49 (s, 0.5H), 8.46 (s, 0.5H),
8.25 (s, 0.5H), 7.63 (s, 0.5H), 7.39 (d, J= 8.8 Hz, 1.0H),
6.98 (d, J= 8.8 Hz, 1.0H), 6.81 (dd, J= 8.8 Hz, J= 8.8 Hz,
2.0H), 3.96 (m, 2.0H), 1.36 (m, 2.0H); 13C NMR (CDCl3,
100 MHz) d= 163.3, 159.2, 156.9, 156.0, 129.9, 129.5, 121.8,
121.5, 115.4, 114.8, 63.8, 63.7, 14.7, 14.7.
N-(2,4-dimethoxyphenyl)formamide (Table 2, entry 11)
CAS: 6639-61-8; 1H NMR (CDCl3, 400 MHz) d= 8.51 (d,
J= 11.6 Hz, 0.3H), 8.37 (s, 0.7H), 8.21 (d, J= 8.4 Hz,
0.7H), 7.57 (s, 0.7H), 7.41 (s, 0.3H), 7.05 (d, J= 8.4 Hz,
0.3H), 6.47 (m, 2.0H), 3.83 (s, 2.1H), 3.81 (s, 0.9H), 3.77 (s,
3.0H); 13C NMR (CDCl3, 100 MHz) d= 161.1, 158.8, 151.7,
141.8, 129.4, 127.4, 126.0, 121.0, 116.3, 116.2, 115.9, 115.7,
112.4, 105.6, 102.6, 99.5, 57.6, 56.7, 56.7, 56.4.
N-(4-chloro-2,5-dimethoxyphenyl)formamide (Table 2,
entry 12) CAS: 6639-58-3; 1H NMR (CDCl3, 400 MHz)
d= 8.67 (d, J= 11.6 Hz, 0.1H), 8.40 (s, 0.9H), 8.16 (s,
0.9H), 7.82 (s, 0.9H), 7.66 (s, 0.1H), 6.91 (s, 0.1H), 6.86 (s,
0.9H), 6.77 (s, 0.1H), 3.84 (s, 3.0H), 3.79 (s, 3.0H); 13C
NMR (CDCl3, 100 MHz) d= 158.8, 149.0, 141.8, 126.0,
116.3, 112.4, 105.6, 56.7, 56.4.
N-phenylacetamide (Table 3, entry 1) CAS: 103-84-4; 1H
NMR (CDCl3, 400 MHz) d= 7.47 (d, J= 8.0 Hz, 2H), 7.43
Table 1 Optimization studies.a
N H
O
+
H
N
O
H
N H
O100°C
Cat.
O
1a 2a
Entry Cat. (1.0 equiv.) Temp. (C) Time (h) Yield (%)b
1 P2O5 100 8 68
2 P2O5 100 12 79
3 P2O5 100 16 79
4 P2O5 (0.5) 100 12 79
5 P2O5 (0.2) 100 12 79
6 P2O5 (0.2) 120 12 85
7 P2O5 (0.2) 60 12 37
8 P2O5 (0.2) R.T. 12 12
9 HCl (0.2) 120 12 96
10 PTSA (0.2) 120 12 92
11 AcOH 120 12 86
12 HCOOH 120 12 90
a All reactions were carried out on 1a 0.25 mmol scale and 1.0 mL
of N,N-dimethyl formamide (DMF).
b GC yield.
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(s, 3H); 13C NMR (CDCl3, 100 MHz) d= 168.4, 137.9, 128.9,
124.3, 119.9, 24.5.
N-p-tolylacetamide (Table 3, entry 2) [23]: 1H NMR
(CDCl3, 400 MHz) d= 7.63 (s, 1H), 7.35 (d, J= 8.0 Hz, 2H),
7.07 (d, J= 8.0 Hz, 2H), 2.27 (s, 3H), 2.11 (s, 3H); 13C NMR
(CDCl3, 100 MHz) d= 168.5, 135.3, 133.9, 129.4, 120.1, 24.3,
20.8.
N-(4-chlorophenyl)acetamide (Table 3, entry 6) [24]: 1H
NMR (CDCl3, 400 MHz) d= 7.45 (s, 1H), 7.41 (d, J= 8.4
Hz, 2H), 7.22 (d, J= 8.4 Hz, 2H), 2.13 (s, 3H); 13C NMR
(CDCl3, 100 MHz) d= 168.4, 136.4, 129.3, 128.9, 121.1, 24.5.
N-(4-methoxyphenyl)acetamide (Table 3, entry 4) [23]: 1H
NMR (CDCl3, 400 MHz) d= 8.05 (s, 1H), 7.37 (d, J= 7.6
Hz, 2H), 6.78 (d, J= 7.6 Hz, 2H), 3.72 (s, 3H), 2.08 (s, 3H);
13C NMR (CDCl3, 100 MHz) d= 168.6, 156.2, 131.4, 121.8,
114.0, 55.4, 24.1.
N-(2,4-dimethoxyphenyl)acetamide (Table 3, entry 11) [25]:
1H NMR (CDCl3, 400 MHz) d= 8.18 (d, J= 8.8 Hz, 1H),
7.54 (s, 1H), 6.47 (s, 1H), 6.46 (d, J= 8.8 Hz, 1H), 3.84 (s,
3H), 3.78 (s, 3H), 2.17 (s, 3H); 13C NMR (CDCl3, 100 MHz)
d= 167.9, 156.3, 149.1, 121.1, 120.8, 103.7, 98.5, 55.6, 55.5,
24.6.
N-(4-chloro-2,5-dimethoxyphenyl)acetamide (Table 3, entry
12) [26]: 1H NMR (CDCl3, 400 MHz) d= 8.23 (s, 1H), 7.73 (s,
1H), 6.87 (s, 1H), 3.87 (s, 3H), 3.83 (s, 3H), 2.19 (s, 3H); 13C
NMR (CDCl3, 100 MHz) d= 168.2, 149.1, 141.6, 127.0,
115.5, 112.1, 104.9, 56.7, 56.3, 24.9.
3. Results and discussion
As shown in Table 1, the reaction of 3-oxo-nphenylbutana-
mide as a model compound was examined under various reac-
tion conditions. Results of the screening study of reaction time
(entries 1–3), amounts of P2O5 (entries 1, 4 and 5) and temper-
ature (entries 5–7) indicated that 12 h, 120 C were the optimalreaction parameters and 0.2 equivalent of P2O5 was enough,
for completion of the designed reaction (entries 1–5). Among
the various catalysts examined, protonic acids were practical
for this transformation and hydrochloric acid (HCl) showed
the highest activity (entries 5, 9–12).
The optimal condition was ﬁnally identiﬁed as HCl
(0.2 equiv.) in DMF at 120 C for 12 h (Table 1, entry 9). Subse-
quently, we investigated the generality of this formylation of
N-aryl acetoacetamides under the optimal condition (Table 2).
Notably, a variety of substituted N-aryl acetoacetamides 1al
could smoothly convert into the corresponding formylated
products N-arylformamides 2al in good to excellent isolated
yields (78–88%). This protocol appeared quite tolerant and
showed no obvious effects of the substrates with respect to the
nature of the substituent(s) (one, two or three electron-donating
(EDG) or electron-withdrawing groups (EWG)), and their posi-
tion (ortho, meta or para) on the aryl ring. For example, the
reactions employing the unsubstituted 3-oxo-N-phenylbutana-
mide (entry 1), para-monosubstituted substrates: 3-oxo-N-p
-tolylbutanamide (entry 4), N-(4-chlorophenyl)-3-oxobutana-
mide (entry 7), N-(4-methoxyphenyl)-3-oxobutanamide (entry
9) and N-(4-ethoxyphenyl)-3-oxobutanamide (entry 10), disub-
stituted substrates: N-(2,5-dichlorophenyl)-3-oxobutanamide
(entry 3), N-(2,4-dimethylphenyl)-3-oxobutanamide (entry 5)
and N-(2,4-dimethoxyphenyl)-3-oxobutanamide (entry 11), or
trisubstitutedN-(4-chloro-2,5-dimethoxyphenyl)-3-oxobutana-
mide (entry 12), all afforded the corresponding N-phenylforma-
mide products in excellent yields (Table 2).
What is the result when employing different N,N-dimeth-
ylamides? Is it possible to achieve the different acylated prod-
ucts? Therefore, we employed dimethylacetamide (DMA) as
the partner of DMF under the identical condition (Table 3).
If the carbonyl came from N,N-dimethylamide, the reaction
would lead to the acetylated products. We were delighted to
ﬁnd that the results only included the acetylated products
and achieved not the formylated products which conﬁrmed
that the carbonyl indeed came from N,N-dimethylamide.
However, it is noteworthy that DMA in this protocol showed
relatively lower reactive activity and gave the corresponding
N-phenylacetamides in moderate isolated yields of 61–75%.
Similarly, the EDG (Me, OMe, entries 2 and 4) and EWG
(Cl, entry 3) on the benzyl ring did not show a signiﬁcant effect
on the reaction.
So far, the mechanism for the present acylation of b-keto
amides catalyzed by HCl has not been completely clear. On
the basis of the literature evidences [27,28], a putative reaction
pathway was deduced according to the above experiments
together with some previous literature results and exempliﬁed
by the formation of 2a (Scheme 2). The ﬁrst step involves
the decomposition reaction of acetoacetanilide resulting in
the intermediate aniline 5 and the protonation of DMF result-
ing in the intermediate 4 [29,30]. Then, the nucleophilic attack
of aniline 5 on the carbonyl carbon took place resulting in the
additional product 6. Then, collapse of 4 took place leading to
the formation of 2a by eliminating one equivalent of dimethyl-
amine [31,32].4. Conclusions
In conclusion, we have developed a novel N-formylated and
N-acetylated method for the synthesis of R-phenyl formamides
Table 2 Scope of the substrates.a
N H
O
+
H
N
O
H
N H
OO
1 2
R R120°C, 12 h
HCl (0.2 equiv.)
Entry 1a–l 2a–l Yield (%)b
1 H
N
O O
H
N H
O
88
2
H
N
O O
H
N H
O
84
3
H
N
O O
Cl
Cl
H
N H
O
Cl
Cl
82
4 H
N
O O
H
N H
O
83
5
H
N
O O
H
N H
O
78
6
H
N
O O
Cl H
N H
O
Cl 87
7 H
N
O O
Cl
H
N H
O
Cl
86
8
H
N
O O
O H
N H
O
O
84
9 H
N
O O
O
H
N H
O
O
80
10 H
N
O O
O
H
N H
O
O
78
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Table 2 (continued)
Entry 1a–l 2a–l Yield (%)b
11
H
N
O O
O
O
H
N H
O
O
O
86
12
H
N
O O
O
Cl
O
H
N H
O
O
Cl
O
88
a All the reactions are carried out using 1.0 mmol of 1, 1.0 mL of N,N-dimethyl formamide at 120 C for 12 h.
b Isolated yield.
Table 3 Scope of the substrates.a
N
O
+
H
N
O
H
N
O120°C, 12 h
HCl (0.2 equiv.)
O
1 3
R R
Entry 1 2 Yield(%)b
1 H
N
O O
H
N
O
66
2 H
N
O O
H
N
O
65
3 H
N
O O
Cl
H
N
O
Cl
63
4 H
N
O
O
O
H
N
O
O
71
5
H
N
O O
O
O
H
N
O
O
O
70
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Table 3 (continued)
Entry 1 2 Yield(%)b
6
H
N
O O
O
Cl
O
H
N
O
O
Cl
O
72
a All the reactions are carried out using 1.0 mmol of 1, 1.0 mL of N,N-dimethylacetamide at 120 C for 12 h.
b Isolated yield.
2aH
N
H
N
O O
1a
NH2
Heat
N
O
H+ HN
OH+
N N
H
OH
N
H
O
5 6
4
Scheme 2 Rational mechanism.
332 C. Chen et al.and acetamides via hydrochloric acid which involved a
sequence of CA bond formation and cleavage of b-keto amides
and N,N-dimethylamides. The readily accessible, stable and
inexpensive reagents and moderate to excellent isolated yields
make the present protocol a complement to the traditional
method for the rapid construction of aryl amides. Now,
further investigations concerning the scope of this reaction,
applications, and especially the mechanistic details are
currently on-going in our group, and the results will be
reported in the near future.
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